These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2642607)

  • 1. Structural differences between a ras oncogene protein and the normal protein.
    Tong LA; de Vos AM; Milburn MV; Jancarik J; Noguchi S; Nishimura S; Miura K; Ohtsuka E; Kim SH
    Nature; 1989 Jan; 337(6202):90-3. PubMed ID: 2642607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
    Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
    J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
    Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
    Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulations of Gly-12-->Val mutant of p21(ras): dynamic inhibition mechanism.
    Futatsugi N; Tsuda M
    Biophys J; 2001 Dec; 81(6):3483-8. PubMed ID: 11721009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
    Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
    Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
    Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
    J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation.
    Pai EF; Kabsch W; Krengel U; Holmes KC; John J; Wittinghofer A
    Nature; 1989 Sep; 341(6239):209-14. PubMed ID: 2476675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
    Tong LA; de Vos AM; Milburn MV; Kim SH
    J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of guanine nucleotide to N-ras p21--a phosphorous and proton magnetic resonance study.
    Grand RJ; Levine BA; Byrd PJ; Gallimore PH
    Oncogene; 1989 Mar; 4(3):355-61. PubMed ID: 2649849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.
    La Vecchio JA; Hamer PJ; Ng SC; Trimpe KL; Carney WP
    Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras.
    Scheffzek K; Lautwein A; Kabsch W; Ahmadian MR; Wittinghofer A
    Nature; 1996 Dec; 384(6609):591-6. PubMed ID: 8955277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
    Warne PH; Viciana PR; Downward J
    Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ras gene family.
    Lowy DR; Willumsen BM
    Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-frequency 94 GHz ENDOR characterization of the metal binding site in wild-type Ras x GDP and its oncogenic mutant G12V in frozen solution.
    Bennati M; Hertel MM; Fritscher J; Prisner TF; Weiden N; Hofweber R; Spörner M; Horn G; Kalbitzer HR
    Biochemistry; 2006 Jan; 45(1):42-50. PubMed ID: 16388579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rasp21 sequences opposite the nucleotide binding pocket are required for GRF-mediated nucleotide release.
    Leonardsen L; DeClue JE; Lybaek H; Lowy DR; Willumsen BM
    Oncogene; 1996 Nov; 13(10):2177-87. PubMed ID: 8950985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and biochemical analysis of ras p21 structure.
    McCormick F; Levenson C; Cole G; Innis M; Clark R
    Symp Fundam Cancer Res; 1986; 39():137-42. PubMed ID: 3321304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.